IGC Pharma Considers Legal Action After Short Seller's Fraud Conviction

Potomac, Wednesday, 29 July 2026.
Following short seller Andrew Left’s federal fraud conviction, IGC Pharma is evaluating legal remedies to recover damages from a 2018 short-selling campaign that wiped out significant shareholder value.